Centerpoint Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-24
Closed -$3K 472
2024
Q4
$3K Hold
24
﹤0.01% 408
2024
Q3
$3K Buy
+24
New +$2.62K ﹤0.01% 427
2018
Q3
Sell
-28
Closed -$3K 367
2018
Q2
$3K Buy
28
+12
+75% +$1.31K ﹤0.01% 273
2018
Q1
$2K Buy
+16
New +$1.86K ﹤0.01% 220

Other funds holding ZBH

Centerpoint Advisors's ZBH Position: Q1 2025 in Review

Centerpoint Advisors sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 24 shares — an estimated $3K sold.

Centerpoint Advisors first reported a position in ZBH in Q1 2018 and held it in 4 quarters. The position peaked at $3K in Q4 2024. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Centerpoint Advisors reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Centerpoint Advisors sold 24 Zimmer Biomet shares in Q1 2025, an estimated $3K.
  • Centerpoint Advisors first reported a position in Zimmer Biomet in Q1 2018 and held it in 4 quarters.
  • Centerpoint Advisors's Zimmer Biomet position peaked at $3K in Q4 2024.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Centerpoint Advisors's 13F filing for Q1 2025, filed 13 May 2025.